Brief analysis of three common treatments for rectal cancer

Rectal cancer is a tumor that is difficult to completely cure, but patients should not give up the treatment of rectal cancer. As long as the treatment method is appropriate, the recurrence of rectal cancer can be avoided, which is beneficial to patients with rectal cancer. What are the common treatments for rectal cancer ? The following is a brief introduction to the common treatments for rectal cancer.

In general, common treatments for rectal cancer include:

1. Radiotherapy: It is one of the common treatments for rectal cancer. Radiotherapy for rectal cancer should be used with caution. Not only should its efficacy on the cancer lesions be considered, but also its damage to the adjacent organs around the rectum should be considered. Clinically, it is generally only used as an adjuvant treatment for rectal cancer surgery. It has certain contraindications and should be used with caution by patients with poor physical fitness. Clinically, it is often combined with biological immunotherapy to reduce its toxic side effects.

2. Surgical treatment: This treatment method for rectal cancer can be used for patients in the middle and late stages who do not have contraindications to surgery. It can remove the metastatic lesions of rectal cancer, but the effect is not ideal. Whether it is early or late stage rectal cancer, surgical treatment is prone to recurrence and metastasis. Postoperative combined biological immunotherapy, using autoimmune cells for anti-cancer treatment, can effectively consolidate the surgical effect and effectively prevent cancer metastasis and recurrence.

3. Chemotherapy: It is mostly used as an adjuvant therapy before and after rectal cancer surgery. This method of rectal cancer treatment is used before rectal cancer surgery. Although it cannot improve the patient's survival rate, it can reduce the tumor to a certain extent, which is conducive to surgical resection and preservation of sphincter function and can reduce the chance of tumor spread during and after surgery. Many studies have shown that the use of sufficient combined chemotherapy after surgery can improve the patient's survival rate. However, because most patients are weak after surgery and cannot tolerate the toxic side effects of chemotherapy, it is often combined with biological immunotherapy in clinical practice to reduce its toxic side effects.

The above are the common treatments for rectal cancer. I hope it will be helpful to everyone. Patients should choose the appropriate treatment for rectal cancer according to their actual condition and must be cautious to avoid causing serious adverse effects on their condition.